Summary: The FDA added new drug-interaction warnings to the prescribing information for Sustiva (efavirenz).
On January 31 the FDA announced that the Sustiva (efavirenz) package insert had been changed “to include drug-drug interaction information regarding coadministration of efavirenz with rifampin, diltiazem, itraconazole, voriconazole, atorvastatin, pravastatin, simvastatin, pimozide and bepridil.”
The complete list of changes is at
And the new version for patients, and also one for physicians, is at
http://www.sustiva.com (click “Patient Information” to download a PDF file — or click “Full U.S. Prescribing Information” and change the ending of the file name from .pl to .pdf is necessary).
Return to home page: www.aidsnews.org
Free subscription to announcements online: send a blank email to email@example.com — and reply to the email request from Yahoo to confirm your subscription. You will receive about five emails or fewer per month and can leave the list at any time. Or just visit www.aidsnews.org to read the articles — no subscription or registration required.
Copyright 2007 by John S. James. We prefer that you link to www.aidsnews.org or a specific article — no permission required. Otherwise permission is granted for nonprofit use. Please check with us (firstname.lastname@example.org) before copying articles more than a year old.